Steve Moore(@SteveMooreRx) 's Twitter Profileg
Steve Moore

@SteveMooreRx

Pharmacist and Owner @CondoPharmacy, Plattsburgh’s longest serving community pharmacy. Rutgers alum, go Knights!

ID:2334432106

linkhttp://www.condopharmacy.com calendar_today09-02-2014 20:46:12

4,8K Tweets

1,0K Followers

828 Following

PSSNY(@NY_Pharmacists) 's Twitter Profile Photo

PSSNY has your back. Karl Williams, RPh, pharmacy professor at St. John Fisher knows this firsthand. As an educator, PSSNY has helped him become a successful pharmacy leader and staunch advocate, relentlessly fighting for the future of our profession. HasYourBack

account_circle
Adam J. Fein(@DrugChannels) 's Twitter Profile Photo

Are physicians underpaid?

Average salaries for , by specialty below. 👇 61% of MDs think they are underpaid

Full Medscape data ==> drugch.nl/4d41PWv

Are physicians underpaid? Average salaries for #physicians, by specialty below. 👇 61% of MDs think they are underpaid Full @Medscape data ==> drugch.nl/4d41PWv
account_circle
NCPA(@Commpharmacy) 's Twitter Profile Photo

Last call – join us today at 4 p.m. ET to learn more about NCPA’s CORE leadership program. This virtual open house will feature CORE co-creator Scott Pace and NCPA’s Drew Register.
👉 bit.ly/4b1kQaq

Last call – join us today at 4 p.m. ET to learn more about NCPA’s CORE leadership program. This virtual open house will feature CORE co-creator Scott Pace and NCPA’s Drew Register. 👉 bit.ly/4b1kQaq
account_circle
Sarah Priestle, PharmD(@sarahpriestle) 's Twitter Profile Photo

“Local pharmacy closings get spotlight in Washington during hearing.” ⁦Sherrod Brown⁩ call out - it’s time for the Senate and the House to reform/regulate the corps ruining community pharmacies and patient choice. ⁦⁦Greg Landsman⁩ abc6onyourside.com/news/local/loc…

account_circle
Shabbir Safdar(@ShabbirSafdar) 's Twitter Profile Photo

1/ Based on court docs in USA v Aminov and data from pharmacists, I show below why PBM underreimbursements are a supply chain safety danger.1

1/ Based on court docs in USA v Aminov and data from pharmacists, I show below why PBM underreimbursements are a supply chain safety danger.1
account_circle
Loretta Boesing(@BoesingLoretta) 's Twitter Profile Photo

🛑The lobbyist from Prime Therapeutics Prime Therapeutics today basically said that legislators need to remove the emotion from watching the closures of America's independent pharmacies due to the monopolization.

I think that Prime could learn to empathize with the pain of patients and…

account_circle
PSSNY(@NY_Pharmacists) 's Twitter Profile Photo

ONE MONTH until the 2024 PSSNY Annual Convention in Brooklyn. This year’s event will include a lineup of educational presentations and countless networking opportunities.

Visit pssny.org to register. Don't wait!

2024Convention

ONE MONTH until the 2024 PSSNY Annual Convention in Brooklyn. This year’s event will include a lineup of educational presentations and countless networking opportunities. Visit pssny.org to register. Don't wait! #PSSNY2024Convention #PSSNY #NYPharmacists
account_circle
Rachel Means(@rachel_means) 's Twitter Profile Photo

Real Doc Speaks Mark Cuban Mark Cuban Cost Plus Drug Company For example:
7,500 life (13K members) group in San Antonio came to us in 2020. With a major carrier ASO/TPA/major PBM, same ole story costs outta control/we need help, caught broker taking $$$$ from carrier/PBM.

account_circle
Rachel Means(@rachel_means) 's Twitter Profile Photo

Real Doc Speaks Overpaying for drugs via Employer plans is the easiest fix. If consultants aren’t advising Clients to move away from the big PBMs, working directly with local/indy pharmacies,& wrapping Mark Cuban Mark Cuban Cost Plus Drug Company sourcing in-they’re either corrupt/taking $$ or lazy/should be fired.

account_circle
Laird Law PLLC(@DanLairdMD) 's Twitter Profile Photo

The number of pharmacy malpractice inquiries at our law firm has increased in the last couple of years.

Pharmacist pay is going down and the working conditions are sometimes horrific. Long hours, unreasonable production expectations, lack of tech support, etc.

I believe that…

The number of pharmacy malpractice inquiries at our law firm has increased in the last couple of years. Pharmacist pay is going down and the working conditions are sometimes horrific. Long hours, unreasonable production expectations, lack of tech support, etc. I believe that…
account_circle
Boy Named Dana(@Smallball303) 's Twitter Profile Photo

Coaching Lebron has to be the worst job in the NBA. No credit for winning and immediately get scapegoated when they lose. A lot of people forget he wanted Spoelstra fired his first year in Miami. Spoelstra is now regarded as one of the best coaches of all time.

account_circle
Real Doc Speaks(@realdocspeaks) 's Twitter Profile Photo

pharmaphorum.com/news/boehringe… Walgreens launched a clinical research business in 2022. According to the article, they will tap into the reserves of patient data to identify suitable subjects for the study. The study will involve those who are overweight, obese, or have diabetes.…

account_circle
Bob Herman(@bobjherman) 's Twitter Profile Photo

I still can't get over this exchange between Elizabeth Warren and Andrew Witty. Semantics aside, UnitedHealth still has 90,000 physicians who have a financial incentive to work with, and look out for, UnitedHealth. That is no small thing.

account_circle
NCPA(@Commpharmacy) 's Twitter Profile Photo

📣Two weeks from today, NCPA's CEO will be attending a protest in St. Louis against Cigna’s Express Scripts, organized by Loretta Boesing of Unite for Safe Medications – and you can join us! It’s the latest in NCPA’s fight for . Click to sign up. bit.ly/4a1xSDF

account_circle
Blake Madden 🏥(@B_Madden4) 's Twitter Profile Photo

Top 25 drugs by total spend and YoY % increase

1. Semaglutide — $38.6 billion (100.1% change from 2022)
2. Adalimumab — $35.3 billion (9.1% change)
3. Apixaban — $22.1 billion (17.1% change)
4. Dulaglutide — $16.3 billion (5.1% change)
5. Empagliflozin — $15.9 billion…

Top 25 drugs by total spend and YoY % increase 1. Semaglutide — $38.6 billion (100.1% change from 2022) 2. Adalimumab — $35.3 billion (9.1% change) 3. Apixaban — $22.1 billion (17.1% change) 4. Dulaglutide — $16.3 billion (5.1% change) 5. Empagliflozin — $15.9 billion…
account_circle
REDBEARD1969(@redlgb1969) 's Twitter Profile Photo

Adam J. Fein Novo Nordisk forcing pharmacies to subsidize the costs is a win for everyone but the pharmacies. maybe they will all still be happy when every non-pbm affiliated pharmacy stops carrying their products. $100+ loss on a single month supply is not unusual for independent pharmacies.

account_circle
MTM.WAG(@MtmWag) 's Twitter Profile Photo

Sir Andrew Witty - when pharmacies are reimbursed below cost, they do go out of business. Just so you know this is “necessarily caused by PBMs”

account_circle
greeny(@JoePharmer) 's Twitter Profile Photo

Weird, when you can’t force people to use your company (like they do with prescriptions) they fail.
Wonder why that is?
Oh that’s probably the same reason why independent pharmacies are busier than ever yet making less money than ever due to reimbursing us under our cost.

account_circle